CV | Twitter | LinkedIn | ResearchGate | ORCID | Operation Naloxone
Lucas Hill graduated from the UMKC School of Pharmacy and completed a combined residency/fellowship in the UPMC Department of Family Medicine. He is now a clinical assistant professor of health outcomes and pharmacy practice at The University of Texas at Austin College of Pharmacy. Dr. Hill precepts learners and cares for patients with complex chronic disease at the CommUnityCare FQHCs. He is Director of Operation Naloxone and Principal Investigator of the Texas Targeted Opioid Response: Overdose Prevention Project. Dr. Hill co-coordinates two years of the Foundations for Interprofessional Collaborative Practice curriculum and serves as faculty advisor for the Student Pharmacist Recovery Network.
Media & Publications
Spectrum News | Trump unveils opioid plan
Drug Topics | Four ways pharmacists are fighting opioid abuse
Spectrum News | In Focus: The Medication Used to Treat Overdoses
Jordan RP, Bratberg J, Congdon HB, Cross LB, Hill LG, et al. The report of the 2016-2017 advocacy standing committee. Am J Pharm Educ. 2017;81(8):S10.
Han JK, Hill LG, Koenig ME, Das N. Naloxone Counseling for Harm Reduction and Patient Engagement. Fam Med. 2017;49(9):730-3.
The Utopian | Minimizing Harm
NPR Marketplace | Overdose Prevention on College Campuses
Corbo JM, Delellis TM, Hill LG, Rindfuss SL. ACE inhibitors or ARBs to prevent CKD in patients with microalbuminuria. Am Fam Physician. 2016;94(8):652-3.
The Daily Texan | College of Pharmacy Combats Opioid Overdose with Campus Campaign
2409 University Avenue | A1910, PHR 2.222G | Austin, TX 78712 | 512.232.7832 | email@example.com